About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 3NCT00520182

Dietary Interventions in Type 2 Obese Diabetic Patients in the Community

Obese patients with type 2 diabetes often fail to loose weight and thus do not succeed in improving their sugar and lipid profiles and remain at high risk for diabetes complications The study enrolle...

Lead sponsor: Ben-Gurion University of the Negev•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Ben-Gurion University of the Negev

Collaborators

The S. Daniel Abraham International Center for Health and Nutrition
Clalit Health Services

Age

30 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Age 30-65years
•2. DM2 diagnosed within 1-10 years
•3. Body mass index (BMI) 27-34 kg/m²
•4. Last HbA1c measurement 7%-10%
•5. Last plasma triglyceride (TG) levels 160-400 mg/dl
•6. Last serum creatinine less than 1.4 mg/dl
•7. No change in diabetes medication for at least three months before entering the study

Exclusion Criteria

•1. Proliferative diabetic retinopathy
•2. Current insulin treatment
•3. Active oncologic or psychiatric disease
•4. Uncontrolled hypothyroidism or hyperthyroidism

Related studies

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

NCT07605572 · Dry Eye Disease (DED), Diabete Mellitus, and more

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

NCT05912647 · Diabetes, Diabetes Type 2

Disentangling the Effect of Brain Insulin Resistance on Brain Health

NCT07374705 · Diabetes Type 2, Diabetes Type 1

FELLAShip to Better Health

NCT07220213 · High Blood Glucose, High Cholesterol, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 20, 2007Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE3

Enrollment259

Start dateMar 2004

Last updatedSep 20, 2007

Condition

Diabetes Type 2

Locations shown

Clalit HMO

Rehovot, Petach Tikva, Ramle, Central District

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 20, 2007Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions